There’s a time in our lives when we start going to more funerals than weddings. Friends start complaining about aches and pains. They can’t remember stuff as well as they could. Diseases like canc

Iradimed Stock News

68 Biggest Movers From Yesterday

IRadimed Sees Q2 Adj. EPS $0.14-$0.15 vs $0.17 Est., Sales $8.8M-$9.0M vs $9.39M Est.; Sees FY19 Adj. EPS $0.69-$0.73 vs $0.72 Est., Sales $38.5M-$39.5M vs $38.88M Est.

IRadimed (IRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Report: Developing Opportunities within Noble Energy, American Vanguard, Calyxt, Medallion ...

Iradimed Gets A Composite Rating Upgrade

IRADIMED CORPORATION Announces FDA 510(k) Clearance For Neonatal Pulse Oximetry And Capnography Monitoring Using Its MRI-Compatible Patient Vital Signs Monitor

On March 26, 2019, Iradimed Entered into Amendment with Fukoku Co., Ltd. Extending Term of Supply Agreement through February 25, 2024

iRadimed Corp (IRMD) Files –…-K for the Fiscal Year Ended on December '–, —…–8

Outperformance and Thinking Differently, Part —: Allocating Time

IRadimed Corporation Sees Q1 Adj. EPS $0.12-$0.13 vs $0.15 Est., Sales $8.3M-$8.5M vs $9.1M Est.; Sees FY19 Adj. EPS $0.69-$0.73 vs $0.73 Est., Sales $38.5M-$39.5M vs $40.2M Est.

IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?

IRADIMED Expects Minor Impact To 2019 Sales After Temporarily Suspending Shipments Of MRI Compatible Patient Vital Signs Monitoring Systems In European Markets

4 Ways Nanomedicine Can Diagnose Diseases

IRADIMED Reports 510(k) Clearance For Its Invasive Blood Pressure Module for Us With MRI-Compatible Patient Vital Signs Monitor

50 Biggest Movers From Yesterday

Top Fintech Company